Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

UNITED THERAPEUTICS (UTHR) Enterprise Value: 2009-2025

Historic Enterprise Value for UNITED THERAPEUTICS (UTHR) over the last 17 years, with Sep 2025 value amounting to $16.2 billion.

  • UNITED THERAPEUTICS's Enterprise Value rose 28.33% to $16.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $6.6 billion, marking a year-over-year increase of 66.21%. This contributed to the annual value of $12.5 billion for FY2024, which is 70.12% up from last year.
  • Per UNITED THERAPEUTICS's latest filing, its Enterprise Value stood at $16.2 billion for Q3 2025, which was up 63.34% from $9.9 billion recorded in Q2 2025.
  • Over the past 5 years, UNITED THERAPEUTICS's Enterprise Value peaked at $16.2 billion during Q3 2025, and registered a low of $5.7 billion during Q1 2021.
  • Over the past 3 years, UNITED THERAPEUTICS's median Enterprise Value value was $9.9 billion (recorded in 2025), while the average stood at $10.1 billion.
  • As far as peak fluctuations go, UNITED THERAPEUTICS's Enterprise Value surged by 118.57% in 2021, and later fell by 25.38% in 2023.
  • UNITED THERAPEUTICS's Enterprise Value (Quarterly) stood at $7.8 billion in 2021, then climbed by 26.09% to $9.8 billion in 2022, then fell by 25.38% to $7.3 billion in 2023, then soared by 70.12% to $12.5 billion in 2024, then climbed by 28.33% to $16.2 billion in 2025.
  • Its Enterprise Value stands at $16.2 billion for Q3 2025, versus $9.9 billion for Q2 2025 and $10.5 billion for Q1 2025.